Answers are grounded in this paper and cite their sources.
OLORECTAL CANCER (CRC) is the third most commonly diagnosed cancer in the United States, with approximately 135,000 new cases expected each year, and the second most common cause of death from cancer, with about 55,000 deaths annually.~ There is evidence that detection of CRC at an early stage by screening can improve survival (secondary prevention)?-4 There is a significant difference in survival between those diagnosed at an early stage compared with those diagnosed at a later stage as demonstrated by estimated 5-year survival rates of 90% for those with localized disease, 60% for those with regional disease, and 5% for those with distant metastases.5Screening identifies individuals with CRC or adenomatous polyps from among those without signs and symptoms of the disease.Screening is effective in the primary prevention of cancer through removal of adenomatous polyps that are precursors of most cancers.6'7 SCREENING FOR COLORECTAL CANCER About 75% of CRCs occur in individuals at average risk, that is with no known risk factor other than age.Screening is advocated for those aged 50 years and older because the incidence of CRC begins to rise significantly between 40 and 50 years of age.8 The recommended options for CRC screening in asymptomatic individuals at average risk are shown in Figure 1.Although the various recommendations differ in their specifics, the essentials are to recommend periodic fecal occult blood testing or sigmoidoscopy, or both in those age 50 years and older.Barium enema can be an additional screening modality.The role of colonoscopy as a screening test for CRC is rapidly evolving.The role of fecal occult blood testing (FOBT) and flexible sigmoidoscopy is discussed briefly before the discussion of the role of colonoscopy in the screening of CRC.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: